<?xml version="1.0" encoding="UTF-8"?>
<p id="para0010">The risk of opioid overdose death is 40 times higher in the two weeks immediately following release (
 <xref rid="bib0019" ref-type="bibr">Ranapurwala et al., 2018</xref>). This is attributable to forced drug abstinence during incarceration which reduces drug tolerance upon release, and a change in the potency of opioids that is primarily driven by the availability of fentanyl. Disruption of the illegal drug supply due to border restrictions as a COVID-19 control measure may lead greater use of fentany, and several counties are already reporting spikes in fentanyl and opioid overdose rates (
 <xref rid="bib0002" ref-type="bibr">American Medical Association, 2020</xref>). People who inject drugs often inject in groups to avoid fatal overdose, yet, this strategy now exposes them to COVID-19. Several studies have also noted elevated substance use after a natural disaster or mass traumatic event (
 <xref rid="bib0009" ref-type="bibr">Cerdá, Tracy &amp; Galea, 2011</xref>; 
 <xref rid="bib0020" ref-type="bibr">Richman, Wislar, Flaherty, Fendrich &amp; Rospenda, 2004</xref>; 
 <xref rid="bib0023" ref-type="bibr">Strathdee et al., 2006</xref>), and the COVID-19 pandemic threatens to trigger a fourth wave of opioid overdose deaths in the US.
</p>
